No Prescription |
 |
 | ||
|
Amace BP Lotrel |
|
| ||
No Prescription » Prescription Drugs 1 » Amace BP Lotrel The combination of amlodipine and benazepril is used to treat high blood pressure. Amlodipine is in a class of medications called calcium channel blockers. It works by relaxing the blood vessels so the heart does not have to pump as hard. Benazepril is in a class of medications called angiotensin-converting enzyme (ACE) inhibitors. It works by decreasing certain chemicals that tighten the blood vessels so blood flows more smoothly.How to use Amlodipine and benazepril OralTake this medication by mouth usually once a day with or without food or as directed by your doctor. Use this medication regularly in order to get the most benefit from it. Remember to use it at the same time each day.Do not take potassium supplements or salt substitutes containing potassium without talking to your doctor or pharmacist first. This medicine can raise your potassium levels which rarely can cause serious side effects such as muscle weakness or very slow heartbeats. Tell your doctor immediately if these effects occur.The dosage is based on your medical condition and response to therapy. It may take 1 to 2 weeks before the full benefit of this drug occurs.It is important to continue taking this medication even if you feel well. Most people with high blood pressure do not feel sick. Buy Amace BP Lotrel and other Prescription Drugs 1 products online at Medstore. Buy Online at Medstore - Click Here!
About Amace BP Lotrel: Product Type: Prescription Drugs 1 Amace BP ( Lotrel Generic Amplodipine/Benazepril ) Amace BP (Lotrel Generic Amplodipine/Benazepril) Lotrel Generic Amplodipine/Benazepril 5/10mg 180 TABLETS 30 TABLETS 90 TABLETS Lotrel Generic Amplodipine/Benazepril Amace BP
View more Prescription Drugs 1 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
